-
Strait of Hormuz impasse squeezes world shipping
-
Oscar-nominated Iranian doc offers different vision of leadership
-
Oscar-nominated docs take on hot-button US social issues
-
'I couldn't breathe': The dark side of Bolivia's silver boom
-
Underground party scene: Israelis celebrate Purim in air raid shelters
-
Flowers, music, and soldiers at funeral of drug lord
-
'Safety and wellbeing' will guide F1 Mideast planning: FIA chief
-
Trump to attend White House Correspondents' dinner
-
Will Iran's missiles drain US interceptor stocks?
-
Trump warns of longer Iran war as violence spreads
-
Energy infrastructure emerges as war target, lifting prices
-
Trump warns of longer Iran war, Rubio points at Israel
-
US urges to 'depart now' from Middle East: Latest developments in Iran war
-
Ecuador launches joint anti-drug operations with US
-
Getafe deal flat Real Madrid La Liga title race blow
-
Rubio, Hezbollah and Qatar: Latest developments in Iran war
-
Rubio says Israel's strike plan triggered US attack on Iran
-
'Thank you, madam president': Melania Trump leads UN Security Council as Iran war rages
-
Bombing Iran, Trump has 'epic fury' but endgame undefined
-
US slaps sanctions on Rwanda military over DR Congo 'violation'
-
US Congress to debate Trump's war powers
-
US appeals court denies Trump bid to delay tariff refund lawsuits
-
Trump warns of longer Iran war
-
Fire-damaged Six nations trophy to be replaced
-
Trump mulls ground troops: latest developments in US-Iran war
-
Middle East war puts shipping firms in tight insurance spot
-
Qatar downs Iran jets as Tehran targets oil and gas in spiralling Gulf crisis
-
UK PM says US will not use British bases in Cyprus
-
Can Anthropic survive taking on Trump's Pentagon?
-
Real Madrid superstar Mbappe in Paris for treatment on knee injury
-
Mideast war risks sending global economy into stagflation
-
Stranded tourists shelter from missile fire in Dubai
-
Iran war spells danger for global airlines
-
Trump doesn't rule out sending US troops into Iran
-
'No aborts. Good luck': Key moments in the US war on Iran
-
Chelsea boss Rosenior warns players over discipline
-
Pentagon chief refuses to rule out 'boots on ground' in Iran
-
Saudi military raises readiness levels after attacks
-
Iran war spreads with strikes across Middle East and beyond
-
Barca must 'make the impossible possible': coach Flick on Atletico cup challenge
-
Furry, frayed & freezing on Milan catwalks: the fashion trends
-
Amsterdam's Rijksmuseum discovers new Rembrandt
-
Olympic comeback queen Brignone ends ski season
-
Key Gulf air hubs caught up in Iran conflict
-
South Korea outclass Iran in Asian Women's Cup opener
-
Liverpool's Slot says his 'football heart' does not like set-piece trend
-
Israel aims fresh attack at Tehran: latest developments in US-Iran war
-
Energy prices soar, stock markets slide on Iran war fallout
-
'No indication' Iran nuclear installations hit: IAEA
-
Showdown looms between Tesla and German union
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / The Investor Summit Group (ISG), today announced that Ori Warshavsky, Chief Operating Officer - US Operations and Jonny Missulawin, Chief Financial Officer of PolyPid Ltd. (Nasdaq:PYPD), a late-stage biopharma company aiming to improve surgical outcomes will be presenting at this year's Investor Summit Virtual Conference on March 11th, 2025.
The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid at the conference should contact their ISG representative.
About PolyPid Ltd.
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional PolyPid information, please visit http://www.polypid.com and follow on Twitter and LinkedIn.
Event: Q1 Investor Summit Virtual Conference
Presentation Time: 10:00 AM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52088
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.
Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.
Sponsors:
ACCESS Newswire
PCG Advisory
QuoteMedia
AGP
MZ Group
News Compliments of ACCESS Newswire
For More Information please visit: https://investorsummitgroup.com/
Or contact [email protected]
SOURCE: PolyPid Ltd.
View the original press release on ACCESS Newswire
P.Stevenson--AMWN